{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:39:38Z","timestamp":1789609178150,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ejogrb.2011.04.040","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T08:07:27Z","timestamp":1308470847000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Essential thrombocythemia and pregnancy"],"prefix":"10.1016","volume":"158","author":[{"given":"Marie-C\u00e9cile","family":"Valera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Parant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vayssiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Arnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Payrastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11739-009-0284-x","article-title":"Essential thrombocythemia: past and present","volume":"4","author":"Fabris","year":"2009","journal-title":"Intern Emerg Med"},{"issue":"November (4)","key":"10.1016\/j.ejogrb.2011.04.040_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<173::AID-HON610>3.0.CO;2-K","article-title":"Age and sex distributions of hematological malignancies in the U.K.","volume":"15","author":"McNally","year":"1997","journal-title":"Hematol Oncol"},{"issue":"June (2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1521-6926(03)00019-7","article-title":"Thrombocythaemia and pregnancy","volume":"16","author":"Elliott","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"May (3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2005.05400.x","article-title":"Pregnancy and its management in the Philadelphia negative myeloproliferative diseases","volume":"129","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"issue":"September (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.blre.2008.03.007","article-title":"Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy","volume":"22","author":"Griesshammer","year":"2008","journal-title":"Blood Rev"},{"issue":"August (4)","key":"10.1016\/j.ejogrb.2011.04.040_bib0030","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"issue":"April (17)","key":"10.1016\/j.ejogrb.2011.04.040_bib0035","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"March (9464)","key":"10.1016\/j.ejogrb.2011.04.040_bib0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"December (24)","key":"10.1016\/j.ejogrb.2011.04.040_bib0045","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-006-6272-7","article-title":"Oncogenic mechanisms in myeloproliferative disorders","volume":"63","author":"Delhommeau","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"June (4 Pt 2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-2006-942763","article-title":"Essential thrombocythemia\/polycythemia vera and pregnancy: the need for an observational study in Europe","volume":"32","author":"Griesshammer","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"September (Suppl. 1)","key":"10.1016\/j.ejogrb.2011.04.040_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199609074361","article-title":"Essential thrombocythemia and pregnancy","volume":"22","author":"Griesshammer","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"July (2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-01-071068","article-title":"Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation","volume":"110","author":"Passamonti","year":"2007","journal-title":"Blood"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1538-7836.2009.03686.x","article-title":"Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies","volume":"8","author":"Passamonti","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"May (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0609.2009.01214.x","article-title":"Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies","volume":"82","author":"Gangat","year":"2009","journal-title":"Eur J Haematol"},{"issue":"June (11)","key":"10.1016\/j.ejogrb.2011.04.040_bib0075","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.1995.00430110137015","article-title":"Outcome analysis of 34 pregnancies in women with essential thrombocythemia","volume":"155","author":"Beressi","year":"1995","journal-title":"Arch Intern Med"},{"issue":"March (3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","article-title":"A single institutional experience with 43 pregnancies in essential thrombocythemia","volume":"66","author":"Wright","year":"2001","journal-title":"Eur J Haematol"},{"issue":"February (1)","key":"10.1016\/j.ejogrb.2011.04.040_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1479-828X.2000.tb03163.x","article-title":"Management of essential thrombocythaemia during pregnancy","volume":"40","author":"Cincotta","year":"2000","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"December (6)","key":"10.1016\/j.ejogrb.2011.04.040_bib0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0609.2004.00324.x","article-title":"Pregnancy in essential thrombocythaemia: experience with 40 pregnancies","volume":"73","author":"Niittyvuopio","year":"2004","journal-title":"Eur J Haematol"},{"issue":"October (10)","key":"10.1016\/j.ejogrb.2011.04.040_bib0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ajh.21504","article-title":"Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry","volume":"84","author":"Melillo","year":"2009","journal-title":"Am J Hematol"},{"issue":"July (3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajh.2830250316","article-title":"Essential thrombocythemia associated with recurrent abortions and fetal growth retardation","volume":"25","author":"Falconer","year":"1987","journal-title":"Am J Hematol"},{"issue":"March (3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajh.10068","article-title":"Pregnancy and abortion in women with essential thrombocythemia","volume":"69","author":"Candoni","year":"2002","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.ejogrb.2011.04.040_bib0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000057634","article-title":"Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature","volume":"107","author":"Vantroyen","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ejogrb.2011.04.040_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-2-3","article-title":"Essential thrombocythemia","volume":"2","author":"Briere","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"September (3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0609.2000.90214.x","article-title":"Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies","volume":"65","author":"Bangerter","year":"2000","journal-title":"Eur J Haematol"},{"issue":"June (6)","key":"10.1016\/j.ejogrb.2011.04.040_bib0125","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3324\/haematol.2009.019190","article-title":"Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients","volume":"95","author":"Palandri","year":"2010","journal-title":"Haematologica"},{"issue":"December (4)","key":"10.1016\/j.ejogrb.2011.04.040_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.2830410405","article-title":"Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome","volume":"41","author":"Chow","year":"1992","journal-title":"Am J Hematol"},{"issue":"December (13)","key":"10.1016\/j.ejogrb.2011.04.040_bib0135","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"issue":"July (1)","key":"10.1016\/j.ejogrb.2011.04.040_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMe058093","article-title":"When and how to treat essential thrombocythemia","volume":"353","author":"Barbui","year":"2005","journal-title":"N Engl J Med"},{"issue":"November (19)","key":"10.1016\/j.ejogrb.2011.04.040_bib0145","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1056\/NEJMc071528","article-title":"JAK2 V617F mutation in unexplained loss of first pregnancy","volume":"357","author":"Mercier","year":"2007","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0150","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"issue":"March (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0155","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07510.x","article-title":"No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage","volume":"144","author":"Dahabreh","year":"2009","journal-title":"Br J Haematol"},{"issue":"December (4)","key":"10.1016\/j.ejogrb.2011.04.040_bib0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0950-3536(98)80043-7","article-title":"Fertility, pregnancy and the management of myeloproliferative disorders","volume":"11","author":"Griesshammer","year":"1998","journal-title":"Baillieres Clin Haematol"},{"issue":"April (2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0165","first-page":"143","article-title":"In utero morphological effects of hydroxyurea on the fetal development in Sprague-Dawley rats","volume":"36","author":"Asano","year":"1987","journal-title":"Jikken Dobutsu"},{"issue":"August (4)","key":"10.1016\/j.ejogrb.2011.04.040_bib0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdrb.20123","article-title":"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea","volume":"80","author":"Liebelt","year":"2007","journal-title":"Birth Defects Res B: Dev Reprod Toxicol"},{"issue":"4","key":"10.1016\/j.ejogrb.2011.04.040_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000253030","article-title":"Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review","volume":"122","author":"Sobas","year":"2009","journal-title":"Acta Haematol"},{"issue":"December (4)","key":"10.1016\/j.ejogrb.2011.04.040_bib0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jca.20101","article-title":"Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia","volume":"21","author":"Yamaguchi","year":"2006","journal-title":"J Clin Apheresis"},{"issue":"December (6)","key":"10.1016\/j.ejogrb.2011.04.040_bib0185","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"March (8898)","key":"10.1016\/j.ejogrb.2011.04.040_bib0190","first-page":"619","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0195","first-page":"1225","article-title":"Increased thromboxane biosynthesis in essential thrombocythemia","volume":"74","author":"Rocca","year":"1995","journal-title":"Thromb Haemost"},{"issue":"May (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0200","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.exphem.2007.01.053","article-title":"V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules","volume":"35","author":"Falanga","year":"2007","journal-title":"Exp Hematol"},{"issue":"May (3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","article-title":"Guideline for investigation and management of adults and children presenting with a thrombocytosis","volume":"149","author":"Harrison","year":"2010","journal-title":"Br J Haematol"},{"issue":"September (1)","key":"10.1016\/j.ejogrb.2011.04.040_bib0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V","article-title":"Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases","volume":"53","author":"Pagliaro","year":"1996","journal-title":"Am J Hematol"},{"issue":"July (2)","key":"10.1016\/j.ejogrb.2011.04.040_bib0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"issue":"January\u2013February (1)","key":"10.1016\/j.ejogrb.2011.04.040_bib0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (third edition)","volume":"35","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2011.04.040_bib0225","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1515\/JPM.2000.047","article-title":"Administration of interferon-alpha during pregnancy: effects on fetus","volume":"28","author":"Hiratsuka","year":"2000","journal-title":"J Perinat Med"},{"issue":"December (6)","key":"10.1016\/j.ejogrb.2011.04.040_bib0230","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ajog.2004.05.001","article-title":"Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review","volume":"191","author":"Martinelli","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"August (8)","key":"10.1016\/j.ejogrb.2011.04.040_bib0235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.jp.7211342","article-title":"Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy","volume":"25","author":"Fritz","year":"2005","journal-title":"J Perinatol"},{"issue":"20","key":"10.1016\/j.ejogrb.2011.04.040_bib0240","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2169\/internalmedicine.45.1879","article-title":"Interferon-alfa treatment of essential thrombocythemia during pregnancy","volume":"45","author":"Iwashita","year":"2006","journal-title":"Intern Med"},{"issue":"November (32)","key":"10.1016\/j.ejogrb.2011.04.040_bib0245","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1200\/JCO.2009.23.6075","article-title":"Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera","volume":"27","author":"Quintas-Cardama","year":"2009","journal-title":"J Clin Oncol"},{"issue":"August (8)","key":"10.1016\/j.ejogrb.2011.04.040_bib0250","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","article-title":"TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"issue":"October (10)","key":"10.1016\/j.ejogrb.2011.04.040_bib0255","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ajh.21508","article-title":"Essential thrombocythemia and pregnancy: observations from recent studies and management recommendations","volume":"84","author":"Tefferi","year":"2009","journal-title":"Am J Hematol"},{"issue":"December (11)","key":"10.1016\/j.ejogrb.2011.04.040_bib0260","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","article-title":"Essential thrombocythemias. Clinical evolutionary and biological data","volume":"58","author":"Bellucci","year":"1986","journal-title":"Cancer"},{"issue":"June (Suppl. 3)","key":"10.1016\/j.ejogrb.2011.04.040_bib0265","first-page":"365","article-title":"Essential thrombocythemia: pregnancy","volume":"76","author":"Leone","year":"1991","journal-title":"Haematologica"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2011.04.040_bib0270","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2796.1999.00614.x","article-title":"Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies","volume":"246","author":"Randi","year":"1999","journal-title":"J Intern Med"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:25:40Z","timestamp":1759555540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211511002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0301211511002569"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.04.040","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essential thrombocythemia and pregnancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}